Methylamine → 3-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-7-chloro-5,6-dihydro-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one

HRID 1378047ノート

反応式

HRID 1378047 の反応式
[Cl:1][C:2]1[C:7]2[C:8](=[O:34])[N:9]([CH3:33])[CH2:10][C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16]3[O:20][N:19]=[C:18]([CH2:21][N:22]4C(=O)C5=CC=CC=C5C4=O)[N:17]=3)[C:6]=2[CH:5]=[CH:4][CH:3]=1.CN>C(O)C>[NH2:22][CH2:21][C:18]1[N:17]=[C:16]([C:15]2[N:14]=[CH:13][N:12]3[C:6]4[CH:5]=[CH:4][CH:3]=[C:2]([Cl:1])[C:7]=4[C:8](=[O:34])[N:9]([CH3:33])[CH2:10][C:11]=23)[O:20][N:19]=1

参加物

4

実験手順

35.1 g (74 mmol) of 7-chloro-5,6-dihydro-5-methyl-3-(3-phthalimidomethyl-1,2,4-oxadiazol-5-yl)-4H-imidazo[1,5-a]-[1,4]benzodiazepin-6-one were stirred with 190 ml of methylamine in ethanol) and 100 ml of ethanol at 80° for 3 hours. The solution was concentrated, the residue was taken up in methylene chloride and 100 ml of 4N hydrochloric acid and the solution was washed three times with methylene chloride. The aqueous phase was made alkaline with 105 ml of 4N sodium hydroxide solution and extracted six times with methylene chloride. After drying the combined organic solutions and evaporating the solvent there were obtained 18.14 g (71%) of 3-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-7-chloro-5,6-dihydro-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one, which was used without further purification as the starting material for the Example described hereinafter.

後処理

  1. concentrationThe solution was concentrated
  2. wash100 ml of 4N hydrochloric acid and the solution was washed three times with methylene chloride
  3. extractionextracted six times with methylene chloride
  4. customAfter drying the combined organic solutions
  5. customevaporating the solvent there

出典と根拠

ORDレコード
ord-39cce4b912134223a80a16acd9cce2c1
出典データセット
uspto-grants-1997_09
特許番号
US05665718

反応ノート

読み込み中…